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Autocrine growth induced by transferrin-like substance
in bladder carcinoma cells
H Tanoguchi, M Tachibana and M Murai
Department of Urology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan
Summary Ample evidence confirms that certain cancer cells have the capacity to produce multiple peptides as growth factors and that
expression of their receptor may act in tumour cell paracrine and/or autocrine loop mechanisms, either by extracellular release of the growth
factor or by the tumour itself. To study the possibility of an autocrine growth mechanism in bladder carcinoma, we investigated the ability of
various bladder carcinoma cell lines to proliferate in serum-free medium. A rat bladder carcinoma cell line, BC47, demonstrated exponential
and density-dependent growth in serum-free medium. Furthermore, conditioned medium from BC47 cells induced growth-stimulating activity
for BC47 cells themselves. Purification and further characterization of this activity was performed by chromatographic methods, SDS-PAGE
and N-terminal amino acid analysis. Finally, we have identified that a transferrin-like 70-kDa protein is found to be the main growth-promoting
factor in this conditioned medium. In addition, specific antibodies against transferrin and the transferrin-receptor inhibit the in vitro growth of
this cell line. Our data suggest that this transferrin-like factor possibly acts as an autocrine growth factorfor cancer cells.
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The relatively autonomous nature of malignant cells has been
known for many years, i.e. they require fewer exogeneous growth
factors for optimal growth than do their counterparts. To explain
this phenomenon, it has been suggested that cells could become
malignant by the endogeneous production of polypeptide growth
factors acting on their producer cells via functional external recep-
tors, allowing phenotypic expression of the peptide by the same
cell that produces it. This process has been termed 'autocrine
secretion' (Sporn and Todaro, 1980; Sporn and Roberts, 1985).
There is now much circumstantial and direct evidence to support
the original hypothesis. Many types of tumour cells release
polypeptide growth factors into their conditioned medium when
grown in cell culture, and these same tumour cells often possess
functional receptors for the released peptide.
The presence ofeither serum components or substances such as
hormones and growth factors is essential to maintain cells in
culture. In analysing the regulatory mechanism ofgrowth factors,
the importance of cells that can proliferate in chemically defined,
serum-free medium without supplements is increasing, because
such cells are likely to synthesize factors with growth-stimulating
activity (Messing et al, 1984; Matsuda et al, 1989) that can be
isolated easily in the absence ofextrinsic growth factors. Recently,
it was demonstrated that bladder carcinoma cells were able to
secrete a variety of autocrine factors, such as tumour-derived
adhesion factor (Akaogi et al, 1994) and granulocyte colony-stim-
ulating factor (Tachibana et al, 1995). The present study was
undertaken to investigate the ability of various bladder carcinoma
cell lines to proliferate in serum-free medium, the purification of
growth-stimulating activity in conditioned medium and the possi-
bility ofan autocrine growth mechanism in bladder carcinoma.
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MATERIALS AND METHODS
Cell lines and culture conditions
Four human bladder carcinoma cell lines (KUI, KU7, T24 and
NBT) were used (Tachibana, 1982). A rat bladder carcinoma cell
line, BC47, which was induced in inbred ACIIN rats by exposure
to N-butyl-N-butanol (4) nitrosamine, was also used. All cell lines
were maintained in minimal essential medium (MEM) with 10%
fetal bovine serum. Cells were trypsinized, washed three times
with Ca2+- and Mg2+-free Hanks' balanced salt solution, counted
and then plated into 25-cm2 tissue culture flasks at densities
ranging from Ix104 to 3x104 cells cm-2 in 5 ml of serum-free
medium. The medium consisted of a 1:1 mixture of Dulbecco's
modified Eagle medium (DMEM)/Ham's F-12 medium containing
hydrocortisone (50 nM), prostaglandin E, (25 ng ml-'), 3,3'-5'-
triiodo-L-thyronine (5 pM), L-glutamine (0.292 mg ml-') and
sodium selenite (10 nM) with reference to the report ofMessing et
al (1982). The cells were incubated at 37°C in a humidified atmos-
phere of5% carbon dioxide and 95% air. Cells were removed from
the flasks by trypsinization, and viable cells (trypan blue dye
exclusion) were counted in a haemocytometer (Burker-Turk) on
days 1-5. The medium was not removed and cells were not
refreshed during the experiments.
Collection and concentration of conditioned medium
Conditioned medium was collected from ongoing cultures ofBC47
cells growing in serum-free medium, when they reached 90%
confluence, was centrifuged at 4000 r.p.m. for 10 min to remove
cellular debris and was stored at -80'C. When a sufficient quantity
had been collected, it was thawed, pooled and concentrated using
an ultrafiltration cell (model 8050, Amicon, WR Grace, Danvers,
MA, USA) and a filter with a 5000 molecular weight cut-off.
Specimens were sterilized by passage through a membrane filter
with 0.45-,um pores and were stored at-80°C until use.
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Cell growth in concentrated serum-free conditioned
medium
BC47 cells were plated at 1 x 104 cells cm-2 in serum-free medium
supplemented with fivefold-concentrated BC47-conditioned
medium (10% ofthe final volume) in 25-cm2 tissue culture flasks.
Growth curves were obtained as described above.
Effect of conditioned media collected from other
bladder carcinoma cell lines on growth of BC47 cells in
serum-free medium
We investigated whether conditioned media collected from NBT,
T24 and KUI cell lines could stimulate the growth of BC47 cells
in serum-free medium. Cell growth was assessed by thymidine
incorporation assay as described in the section entitled
Proliferation assay.
Effect of medium replenishment on growth of BC47
cells in serum-free medium
BC47 cells (3 x 104 cells cm-2) were plated into serum-free
medium in 25-cm2 tissue culture flasks and were incubated at
37°C. The medium was replaced with fresh medium at 24 h inter-
vals. Sham treatment by removing and returning the medium was
also done at 24 h intervals (Masuda et al, 1988). Cell counting was
performed as described above.
Gel filtration of conditioned medium
Two hundred microlitres of the 50-fold concentrated BC47-
conditioned medium was applied to a 1.0 x 30-cm Superose 12
precolumn (Pharmacia LKB Biotechnology, Uppsala, Sweden)
equilibrated with 0.05 M Tris-HCl (pH 8.6). The column was
eluted at room temperature with 0.05 M Tris-HCl (pH 8.6) at aflow
rate of30 ml h-', and the absorbance ofthe eluate was monitored at
280 nm. Two-millilitre fractions were collected, sterilized by
passage through a membrane filter with 0.22-pm pores and stored
at -80°C until assay for biological activity.
Proliferation assay
BC47 cells (3.2 x 103 cells per well) were dispersed into 96-well
round-bottom plates with 175 pl of serum-free medium and were
incubated for 24 h at 37°C in a humidified atmosphere of 5%
carbon dioxide and 95% air. Then 25 ,ul of [3H]thymidine (20gCi
ml-') was added to each well immediately after the addition of
25 pl aliquots of the fractions obtained by gel filtration, and
culture was continued for a further 6 h. Subsequently, the medium
was removed, the cells were harvested by cell harvester, and the
radioactivity was analysed by a liquid scintillation counter
(Beckman LS 9800; Beckman Instruments, Fullerton, CA, USA).
Results are expressed as a percentage of the c.p.m. obtained in
control culture.
Anion exchange chromatography
After using ultrafiltration to concentrate the biologically active
fractions obtained by gel filtration, the retentate was applied to a
1.6 x 10 cm HiLoad Q Sepharose HP precolumn (Pharmacia)
equilibrated with 0.05 M Tris-HCl (pH 8.6) at room temperature.
Bound material was eluted with a continuous 130-ml linear.0-
0.5 M sodium chloride gradient in 0.05 M Tris-HCl (pH 8.6), and
the eluate was monitored at 280 nm. Five-millilitre fractions were
collected at a flow rate of 150 ml h-I at room temperature, steril-
izedby passagethrough a membrane filter with 0.22 ,um pores and
assayed forbiological activity as described above.
SDS-PAGE
The most active fraction prepared by gel filtration and anion
exchange chromatography, together with the fractions before and
behind the active one, were separated by SDS-PAGE as reported
previously (Laemmli, 1970). Samples were heated at 95°C for
3 min with 1.5% dithiothreitol before application to a 7.5% poly-
acrylamide gel. The resulting gel was stained by silver staining kit
(Pharmacia). Molecular weight markers were used for protein
markers (Pharmacia) with phosphorylase-b (94kDa), albumin
(67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30kDa),
trypsin inhibitor (20 kDa) and a-lactalbumin (14 kDa).
Amino acid analysis
After SDS-PAGE under reducing conditions, the protein bands
were transferred to a polyvinylidene difluoride membrane. The
amino (N)-terminal amino acid sequence of the 70-kDa protein
band that corresponded to the biological activity was analysed
with a gas-phase protein sequencer (PPSQ-10; Shimadzu, Kyoto,
Japan). Its amino acid sequence analysis was performed by Tokyo
Research Laboratories, Kyowa Hakko Kogyo (Tokyo, Japan).
Antibody studies
For the antibody studies, the mouse anti-human transferrin mono-
clonal antibody (Cosmo Bio, Tokyo, Japan) was used. This anti-
body is a mouse IgG molecule that has been shown to bind human
transferrin specifically. BC47 cells were plated at 1 x 106 cells in
5 ml of serum-free medium added at various concentrations of
antibodies (5 gg ml-', 10 jg ml-' and 20 ,ug ml-') in 25-cm2 tissue
culture flask. The cells were incubated at 37°C in a humidified
atmosphere of5% carbon dioxide and 95% air. Twenty-four hours
and 48 h later, bromodeoxyuridine was added at a final concentra-
tion of 30 jg ml' per flask, and the cells were reincubated for
another hours. After bromodeoxyuridine labelling, the cells were
trypsinized, washed three times with phosphate-buffered saline,
and DNA-synthesizing cells were determined by the DNA-
bromodeoxyuridine double-staining method using flow cytometry
as reported previously (Tachibana et al, 1991). The same experi-
ment was made with various amounts (5 jg ml-', 15 jig ml' and
30 jig ml-') of the mouse anti-human transferrin receptor mono-
clonal antibody (Oncogene Science, NY, USA). Also, we investi-
gated the effect of anti-human transferrin antibody on the
growth-stimulating activity in BC47-conditioned medium. BC47
cells were plated at 1 x 104 cells cm-2 in serum-free medium
supplemented with both fivefold-concentrated BC47-conditioned
medium and anti-human transferrin antibody (20 jg ml-') in 25-
cm2 tissue culture flasks. As a control, anti-human IgG antibody
was used. To eliminate the possibility that the anti-human trans-
ferrin antibody was toxic to the cells, the same experiment was
performed with KU7 cells that could grow well in serum-free
medium, independent of plating cell density. Growth curves were
obtained as described above.
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Figure 1 Growth of bladder carcinoma cell lines plated at 3 xl04 cells cm-2
in serum-free medium. Cell counting was performed by the trypan blue dye
exclusion method. All studies were performed in duplicate with the mean
values represented. The symbols indicate cell lines from: 0, BC47; *, KU1;
A, NBT; O, T24; and A, KU7
RESULTS
Growth of bladder carcinoma cell lines in serum-free
medium
Five bladder carcinoma cell lines were cultured in serum-free
medium (Figure 1). As demonstrated by cell counts after a 24 h
incubation period, the plating efficiency of three cell lines, with
the exception of KUI and BC47, were considerably reduced in
serum-free medium. KUl cells could survive without proliferation
until 48 h, however, it could not be cultivated thereafter. On the
other hand, BC47 cells grew well when plated at a density of 3 x
104cells cm-2, but this cell line did not grow whenplated at a lower
density (Figure 2). Thus, it seems likely that the growth of BC47
cells in this serum-free medium was dependent on the plating cell
density. Conversely, KU7 cells demonstrated vigorous growth in
serum-free medium, regardless of plating cell density. T24 cells
survived without proliferation during an experiment, while NBT
cells could not be cultivated in serum-free medium. Fivefold-
concentrated BC47-conditioned medium was found to stimulate
the proliferation ofBC47 cells plated in serum-free medium at 1 x
104 cells cm-2 (Figure 2). However, conditioned media from the
other human bladder carcinoma cell lines NBT, T24 and KU1 did
not exhibit a growth-stimulating activity on BC47 cell comparable
to the effect of conditioned medium collected from BC47 (Figure
3). Moreover, when compared with control cultures, a significant
decrease in cell numbers was observed by changing the medium at
24-h intervals during incubation for a period of 72 h (Table 1).
These experiments suggest that growth-stimulating activity of
conditioned medium collected from BC47 is not derived from a
pre-existing substance in serum-free medium but is secreted by
only BC47 cells growing in serum-free culture.
Partial purification of growth-stimulating activity
produced by BC47 cells
When concentrated BC47-conditioned medium was separated by
gel filtration, the peak ofgrowth-stimulating activity was observed
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Figure 2 Growth of BC47 and KU7 cells plated at 104 cells cm-2 in serum-
free medium. Supplementation of BC47-conditioned medium made it possible
for BC47 cells to grow at a low density. All studies were performed in
duplicate with the mean values represented. The symbols indicate cell lines
from: 0, BC47 added to 10% conditioned medium; 0, BC47; and A, KU7
Table 1 Effect of medium change on the growth of BC47 cells in serum-free
medium
No. of cells perflask after a 72-h
incubation period (x 106 cells)
Control 2.42 ± 0.10
Sham treatment 2.19± 0.08*
Medium change 1.80 ± 0.21*
BC47 cells were plated at 3 x 104 cells cm-2 tissue culture flasks. The
medium was replaced with fresh medium at 24-h intervals. Sham treatment
by removing the medium and then returning it was performed at 24-h
intervals. All studies were performed in duplicate. Number of cells were
expressed as mean ± s.d. *Not significant; **P< 0.01 compared with the
control.
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Figure 3 Effect of conditioned media collected from other bladder
carcinoma cell lines on growth of BC47 cells in serum-free medium. BC47
cells were plated at a density of 104 cells cm-2 in 96-well plates. Twenty-five
microlitres of conditioned medium of the various cell lines was added to each
well. Cells were pulsed with 0.5gCi [3H]thymidine for 6 h. The results ( ) are
expressed as a percentage of c.p.m. obtained in control (E) and represent
the mean values in triplicate
in the high-molecular-weight fraction (Figure 4). In the anion-
exchange chromatography, growth-stimulating activity was bound
to the column atpH 8.6 and was eluted from the column by approx-
imately 0.26 M sodium chloride (Figure 5). The lower-molecular-
weight fractions with a minor activity by gel filtration were also
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Figure 4 Gel filtration of BC47-conditioned medium. Two hundred
microlitres of 50-fold-concentrated conditioned medium was applied to a
1.Ox30-cm Superose 12 precolumn equilibrated with 0.05 M Tris-HCI
(pH 8.6). Fractions (2 ml) were collected and their stimulation of [3H]thymidine
incorporation by BC47 cells was determined. The results are expressed as a
percentage of c.p.m. obtained in control and represent the mean values in
triplicate. The arrow indicates the peak relevant to the growth-stimulating
activity.-, Absorbance at 280 nm; 0-0, [3H]thymidine incorporation
analysed in the same manner; however, no growth-stimulating
activity couldbe detected. Thebiologically active fraction obtained
from gel filtration was applied to SDS-PAGE. As demonstrated in
Figure 6, a light band at 70kDa, which was close to the major dark
band, was seen. When the active fraction from anion-exchange
chromatography was also applied to SDS-PAGE, this 70-kDa band
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comigrated with the dark band. However, the 70-kDa band was
considered to correspond to growth-stimulating activity because of
an increase in its staining intensity according to purification.
Structural analysis of the purified 70-kDa protein
In order to examine the relationship between the purified 70-kDa
protein and otherproteins, its N-terminal amino acid sequence was
analysed with an automated protein sequencer. The N-terminal
sequence up to the 17th amino acid residue was determined to be
S-A-G-W-N-I-P-I-G-L-L-Y-X-D-L-P-E-, in which X seemed to be
C (Cys). As a result of an investigation of the homology using
the protein database, this sequence was found to be completely
identical to the sequence of amino acid residues 125-141 from
the N-terminus of human transferrin (MacGillivray et al, 1982;
Yang et al; 1984).
Inhibition of transferrin-like growth-stimulating activity
by antibodies against human transferrin and transferrin
receptor
To investigate the possibility of an autocrine mechanism in this
system, monoclonal antibodies against human transferrin and
transferrin receptor were tested for their effect on the proliferation
ofBC47 cells. Figure 7 showed that adecrease in the proportion of
cells in S-phase was seen in a dose-dependent fashion by adding
the anti-human transferrin antibody. Also, as shown in Figure 8,
the decrease in the number ofcells in S-phase ofthe cell cycle was
manifested by adding the anti-human transferrin receptor anti-
body. As demonstrated previously, BC47-conditioned medium
stimulated the proliferation of BC47 cells plated at 1 x 104 cells
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Figure 5 Anion exchange chromatography of the high-molecular-weight fraction from gel filtration. The active fraction was applied to a 1.6x1O-cm HiLoad Q
Sepharose HP precolumn equilibrated with 0.05 M Tris-HCI (pH 8.6). Bound materials were eluted with a linear 0-0.5 M sodium chloride gradient in the same
buffer. Fractions (5 ml) were collected, and their stimulation of [3H]thymidine incorporation by BC47 cells was evaluated. The results are expressed as a
percentage of c.p.m. obtained in control and represent the mean values in triplicate. The arrow indicates the peak relevant to the growth-stimulating activity.
-, Absorbance at 280 nm; 0-0 [3H]thymidine incorporation
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Figure 6 SDS-PAGE of purified active fractions from conditioned medium
by BC47 cells. Samples were run on 7.5% polyacrylamide gel under reducing
conditions. The lanes indicate samples from: (A) fraction 2 on gel filtration,
(B) fraction 3 (the most active fraction) on gel filtration, (C) fraction 4 on gel
filtration and (D) the most active fraction on anion exchange chromatography.
The arrows to the left of the figure indicate the molecular weight markers in
kDa. The arrow to the right of the figure indicates the growth-stimulating
activity
cm-2 in serum-free medium. However, the stimulatory effect of
BC47-conditioned medium was largely blocked by adding the
anti-human transferrin antibody, while KU7 cells grew well in the
same experiment. Also, anti-human IgG antibody had no effect on
the growth ofBC47 in the serum-free medium (Figure 9).
DISCUSSION
Serum has been used in nutritive media to supply to cultured cells
a growth-stimulating activity with a complex, undefined and vari-
able nature. The substitution of serum by standard media supple-
mented with nutrients and hormones of known composition and
concentration simplifies the investigation of all classes of growth
factors. Growth factors play a central role in cell transformation
(Heldin and Westermark, 1984). In general, as tumours progress to
a more malignant phenotype, they become less dependent on
serum-derived growth factors for their growth in vitro and begin
producing polypeptide growth factors (Rodeck and Herlyn, 1991),
suggesting that autocrine growth mechanisms may be involved in
malignant transformation. In several cell lines, it has been reported
that the production of autocrine growth factors does occur. It has
been shown that tumour cell growth can be regulated by normal
growth factors, and the products of many viral and cellular onco-
genes have been found to be related to growth factors or growth
factor receptors (Wong and Passaro, 1989).
The growth of BC47 cells in serum-free medium demonstrated
considerable dependence upon a high cell density. This was
presumably not only because of technical factors such as the
reduced plating efficiency but also because of an inferent density-
dependence of the growth of BC47 cells in serum-free medium.
Also, the number ofproliferating BC47 cells decreased by periodic
medium exchange. This phenomenon has been explained by the
production ofmolecules that have a mitogenic effect and are trans-
mitted between neighbouring cells. Cell proliferation apparently
occurs when these substances reach a sufficient concentration to be
stimulatory when bound to the target cells. The supematant of
growing cell cultures is therefore likely to contain not only growth-
promoting factors (Cross and Dexter, 1991) but also various secre-
tory factors (Liotta et al, 1986; Koshikawa et al, 1992; Akaogi et al,
1994). The present study also showed that culture of BC47 cells in
serum-free conditions provided a suitable system for investigating
such growth factors. We have shown that BC47 cells are able to
secrete a 70-kDa molecule, which has growth-stimulating activity
on BC47 cells themselves, into the chemically defined synthetic
medium without transferrin. In addition, the N-terminal amino acid
sequence ofthis molecule is homologous to the sequence of amino
acid residues 125-141 of human transferrin, except for lacking
amino acid residues 1-124 from N-terminus. BC47 is a rat bladder
carcinoma cell line; however, strong homology is claimed to exist
between the amino acid sequence of human and non-human trans-
ferrins (Bowman et al, 1988). Consequently, the bioactivity of
human and rattransferrin is thought to be very similar, and we used
monoclonal antibody to human transferrin and transferrin receptor
in the blocking experiment.
Transferrin, the major iron-transporting protein in plasma, is a
glycoprotein with a molecular weight of 80 kDa (MacGillivray et
al, 1982). It transports ferric iron from the intestine, reticulo-
endothelial system and liver parenchymal cells to all proliferating
cells in the body. Previous experiments strongly indicate that the
only function of transferrin in supporting cell proliferation is
supplying cells with iron. Numerous in vitro studies have demon-
strated the requirement of transferrin for proliferation and/or DNA
synthesis, and thus transferrin has been included among the factors
required for cell growth in serum-free media (Barnes and Sato,
1980). As discussed on previous reports (Shewale and Brew, 1982;
MacGillivray et al, 1983), chemical and physical evidence indi-
cates that the ferric iron bound at each site in transferrin is liganded
with 1 or 2 histidyl residues, 2 or 3 tyrosines and a bicarbonate ion
that probably interacts with an arginyl side chain. In the case of
metal-binding protein and enzymes, in which the locations of
binding site residues have been determined, two metal-liganding
residues have been found to be no more than four residues apart in
the amino acid sequence (Liljas and Rossman, 1974), presumably
to form an initial locus for weak association before the formation
of the complete binding site by conformational adjustments. On
this basis, the only two candidates for components of the binding
sites that are sufficiently close in the sequence are considered to be
tyrosines 185 and 188 in the N-terminal domain and 514 and 517 in
the carboxy-terminal domain of transferrin (Schwale and Brew,
1982). The 'transferin-like' molecule in serum-free medium condi-
tioned by BC47 cells is likely to contain the above sequence of
amino acids; therefore, this molecule is considered to act as an
iron-carrier protein similar to native transferrin.
Another line ofinvestigation revealed that transferrin may serve a
role as a growth factor, independent ofits function as atransporter of
iron (May and Cuatrecasas, 1985). Transferrin is considered to be an
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Figure 7 DNA and bromodeoxyuridine (BrdU) two-colour analysis of BC47 cells with anti-transferrin antibody by flow cytometer. Bivariate
bromodeoxyuridine/DNA (green/red) fluorescence distributions are displayed in a dot-density graph with DNA distribution on axis of abscissa and
bromodeoxyuridine fluorescence on axis of ordinate. BC47 cells were plated at 1 x 106 cells in 5 ml of medium in 25-cm2 tissue culture flasks and various
concentrations of antibodies were added: (A) none, (B) 5 pg ml-, (C) 10 pg ml, (D) 20 pg mi-'. The figures in each dot graph indicate the percentage of cells
with positive staining
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Figure 8 DNA and bromodeoxyuridine (BrdU) two-colour analysis of BC47 cells with anti-transferrin receptor antibody by flow cytometer. Bivariate
bromodeoxyuridine/DNA (green/red) fluorescence distributions are displayed in the same dot-density graph as Figure 7. BC47 cells were plated at 1 x 106 cells
in 5 ml of medium in 25-cm2 tissue culture flasks. Various amounts of antibodies were added. (A) None, (B) 5 ,ig ml-', (C) 15 igg ml-', (D) 30 gg ml-'. The figures
in each dot graph indicate the percentage of cells with positive staining
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Figure 9 Effect of anti-transferrin antibody on growth-stimulating activity
in BC47-conditioned medium. BC47 cells and KU7 cells were plated at
104 cells cm-2 in serum-free medium. At indicated days, the viable cells were
counted and the mean values of duplicate experiments were represented.
The symbols indicate cell lines from: 0, BC47 supplemented with 10%
conditioned medium; rO, BC47 supplemented with 10% conditioned
medium and anti-transferrin antibody (20 ,ug ml-'); A, BC47 supplemented
with anti-human IgG; and *, KU7 supplemented with anti-transferrin antibody
(20 jg ml-')
autocrine regulator of cell proliferation in malignant tumour cells,
where it may also be largely responsible for acquisition of serum
independence (Vostrejs et al, 1988; Shapiro and Wagner, 1989).
Growth factors exert their mitogenic effect by interaction with
specific cell surface receptors on responsive cells. A prerequisite for
autocrine growth stimulation is that the same cell both produces a
growth factor and expresses the corresponding receptor. There is
muchevidencethattumourcell lines growninvitrohavethecapacity
to produce multiple growth factors that can act on the tumour cells
themselves. Furthermore, tumour cell lines have provided examples
ofautocrine-stimulated cells for which, it is claimed, antibody to the
growth factor can prevent cellularproliferation.
In the present study, it was shown that in transferrin-free serum-
free medium BC47 cells exhibited growth that was dependent on
the number of cells seeded, that the number of growing cells
decreased as a result ofregularly scheduled medium exchange and
that, when conditioned medium was added to seeded numbers of
BC47 cells that were incapable of growing, they became able to
grow. It was also demonstrated that the amino acid sequence ofthe
protein in the BC47-conditioned medium that showed growth-stim-
ulating activity resembled that of transferrin, that anti-transferrin
monoclonal antibody seemed to specifically block transferrin and
the number of BC47 cells in the S-phase decreased concentration-
dependently with this anti-transferrin monoclonal antibody, and
that BC47 cell growth itself was inhibited by anti-transferrin
monoclonal antibody. All of these findings strongly suggest that a
'transferrin-like' substance is a prominent component of the
growth-stimulating activity produced by BC47 cells growing in
serum-free medium, although immunoprecipitation of the condi-
tioned medium and cell lysate is necessary to directly prove that
BC47 cells produce a 'transferrin-like' substance. Expression ofthe
transferrin receptor varied according to the cells, it was hardly
detected at all in most somatic cells, which were in the resting
phase. High concentrations are said to be present in cells that are
actively growing, such as cancer cells and placental cells
(Trowbridge and Omary, 1981), however, and we confirmed it to be
present in BC47 cells as well. Furthermore, the monoclonal anti-
body to transferrin receptor is known to have very high specificity.
Thus, the facts that, in the experiment in which monoclonal anti-
body to transferrin receptor was used, the number of S-phase cells
decreased in a concentration-dependent manner, that no cytotoxic
effect of the monoclonal antibodies themselves was observed, that
notransferrin was contained in the serum-free medium andthathigh
homology was found in the amino acid sequence ofthe 'transferrin-
like' substance and transferrin strongly suggest that the 'transferrin-
like' substance expresses its growth promoting action through
transferrin receptors. These results also show that this 'transferrin-
like' substance may act in 'public' or through an extracellular
autocrine mechanism (Browder et al, 1989; Lang and Burgess,
1990). Specialized cellular proliferation may be limited by insuffi-
cient delivery of transferrin-bound iron from plasma during situa-
tions when iron is being withheld from the circulation. To evade the
difficulty ofobtaining iron, certain malignant cells have the ability
to produce the 'transferrin-like' substance (Kitada and Hays, 1985;
Morrone et al, 1988; Dittman and Petrides, 1991; Gruber et al,
1993) as well as native serum transferrin (Vostrejs et al, 1988;
Vandewalle et al, 1989; Ohkawa et al, 1990; Stackpole et al; 1995).
It could be hypothesized, therefore, that the capability of a specific
subset ofhuman bladdercarcinomas to synthesize transferrin and/or
a 'transferrin-like' substance might provide a source of available
iron to support localized proliferation ofbladder carcinoma cells in
vivo in areas not well vascularized. In addition, the additional iden-
tification of such autocrine growth factors as the 'transferrin-like'
substance and/or transferrin could lead to new therapeutic strategies
forthe treatment ofbladder carcinoma in the future.
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